Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data
JMIR Research Protocols · 2025
DOI: 10.2196/56519 ↗At a glance
Studienprotokoll in JMIR Research Protocols, 2025. Written by Erlina Burhan and 8 co-authors. Institution: Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia. Major MEDLINE topics: COVID-19, COVID-19 Vaccines, Vaccine Efficacy. 37 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2 are the five common COVID-19 vaccines used in Jakarta. Randomized controlled trials have provided robust evidence of the safety and efficacy profile of these vaccines, but their real-world vaccine effectiveness against symptomatic COVID-19 and deaths in communities with social inequalities and health care constraints remains unclear.
Objective
This study aims to evaluate the real-world effectiveness of these COVID-19 vaccines during the waves associated with the Delta and Omicron variants by analyzing existing electronic health care sources.
Methods
A population-based study with a test-negative case-control design will be used to evaluate COVID-19 vaccine effectiveness in Jakarta, focusing on the Delta and Omicron waves. It includes adults 18 years and older who underwent reverse transcription polymerase chain reaction testing for symptomatic COVID-19, classifying them as cases or controls based on their test results. The analysis will consider multiple COVID-19 vaccines introduced during these periods, with participants categorized by vaccination status. Several potential confounders will be assessed, including demographic factors and comorbidities. Data will be linked from various health datasets, and statistical analyses will be performed to determine vaccine effectiveness and potential waning immunity over time. After data linkage, patients’ identities will be encrypted.
Results
The research, funded from 2022 to 2024, involved proposal preparation and ethical review in 2023 and enrollment from early 2024 to July 2024, resulting in about 4 million linked data points. Data analysis is ongoing, with initial results expected for publication in early 2025.
Conclusions
This study will be the first to evaluate the effectiveness of different types of COVID-19 vaccines (inactivated, viral-vector, and mRNA) used in Jakarta during the pandemic, providing valuable scientific evidence to inform future vaccination strategies in the country. International Registered Report Identifier (IRRID) DERR1-10.2196/56519
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia.
- Indonesian Society of Respirology, Jakarta, Indonesia.
- Respiratory Programmatic Implementation and Research Institute, Jakarta, Indonesia.
- Faculty of Public Health, Universitas Indonesia, Depok, Indonesia.
ORCID profiles: Erlina Burhan, Farchan Azzumar, Fira Alyssa Gabriella Sinuraya, Muhammad Ilham Dhiya Rakasiwi, Ihya Akbar, Farhan Mubarak, Anggit Tresna Rengganis, Rizky Abi Rachmadi, Hera Afidjati
Cite
APA
Burhan, E., Azzumar, F., Sinuraya, F. A. G., Rakasiwi, M. I. D., Akbar, I., Mubarak, F., Rengganis, A. T., Rachmadi, R. A., & Afidjati, H. (2025). Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data. JMIR Research Protocols. https://doi.org/10.2196/56519
Vancouver
Burhan E, Azzumar F, Sinuraya FAG, Rakasiwi MID, Akbar I, Mubarak F, et al. Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data. JMIR Research Protocols. 2025. doi:10.2196/56519
BibTeX
@article{Burhan2025,
author = {Burhan, Erlina and Azzumar, Farchan and Sinuraya, Fira Alyssa Gabriella and Rakasiwi, Muhammad Ilham Dhiya and Akbar, Ihya and Mubarak, Farhan and Rengganis, Anggit Tresna and Rachmadi, Rizky Abi and Afidjati, Hera},
title = {Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/56519}
}
EUVIMED